•
Jun 30, 2020

Quanterix Q2 2020 Earnings Report

Quanterix reported financial results for the second quarter of 2020, exceeding expectations and laying the groundwork for recovery.

Key Takeaways

Quanterix reported a strong second quarter, exceeding expectations despite challenges from the coronavirus pandemic. The company has been quick to respond to the crisis with critical testing advances and has made gains in neurology.

Expanded Accelerator Services capacity to support customers undergoing disruptions.

Enhanced customer satisfaction and loyalty.

Enabled growth in Lab Services (+95% in the 1H 2020 vs 1H 2019).

Laid the foundation for conducting population studies and building a Specialty Lab infrastructure for Laboratory Developed Testing (LDT) in the future.

Total Revenue
$13.1M
Previous year: $13.5M
-3.0%
EPS
-$0.43
Previous year: -$0.42
+2.4%

Quanterix

Quanterix

Forward Guidance

Quanterix is encouraged by its ability to pivot to capitalize on new opportunities, the validation it’s received via hundreds of peer-reviewed journals, and the opportunity before it to support public health at a critical time in history.